Nikole Kimes | Co-Founder and Executive Vice President
Siolta Therapeutics

Nikole Kimes, Co-Founder and Executive Vice President, Siolta Therapeutics

Dr. Nikole Kimes is Co-Founder and Executive Vice President of Siolta Therapeutics, a San Francisco-based biotech company leading the development of novel microbiome-focused precision strategies for the prevention and treatment of inflammatory diseases. Her training in environmental and human microbial ecology, supported by a National Science Foundation Fellowship and more recently as a postdoctoral scholar in the laboratory of Dr. Susan Lynch at the University of California San Francisco, have afforded her the foundation from which the translational research program at Siolta Therapeutics has developed. Nikole is leading Siolta’s efforts to leverage microbiota data to improve patient stratification and develop precision microbial therapeutics to re-engineer the microbiome composition and metabolic function in the gastrointestinal tract.

Appearances:



Precision 2018 Day 3 @ 10:15

A gut feeling: using microbiome manipulation to treat allergic asthma

  • Understanding the human microbiome from a system perspective
  • Leveraging clinical data to establish human-first rationale for patient stratification and drug development
  • Utilizing a rationally designed microbial consortia for the treatment and prevention of allergic asthma

back to speakers